An Acupuncture Study for Cancer Survivors With Joint Pain

Part of paid clinical trials in New York, New York.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT06814977
Status
Recruiting

Conditions

  • Cancer Survivor

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Acupuncture — PROCEDURE
    Acupuncture is a non-pharmacological intervention that does not involve the use of any therapeutic agents or devices. Participants will receive 10 weekly treatments over 10 weeks.

Study Details

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

Key Dates

Start date
Jan 31, 2025
Status verified
Oct 2025
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
60 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Acupuncture
    Participants will receive 10 weekly acupuncture treatments over 10 weeks.
  • No Intervention: Usual Care
    Participants will receive standard medical care, including pain medications and other treatments

Primary Outcome Measure

Study feasibility as measured by rates of enrollment [ Time Frame: 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Cancer Center (All protocol activites)New YorkNew York10065
Kevin Liou, MD
646-608-8563
Jamaica Hospital Medical CenterRichmond HillNew York11418
Rosa Nouvini, MD
(718) 206-6000

Find similar trials in New York, NY

Related Studies